Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduces the severity of secondary tricuspid regurgitation (TR) and improves quality of life compares to guideline-directed medical therapy (GDMT) alone, according to 12-month follow-up data from the TRI.Fr study.